CIBC Private Wealth Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$29.9K Sell
484
-616
-56% -$37.7K ﹤0.01% 2008
2025
Q3
$68.6K Buy
1,100
+647
+143% +$45K ﹤0.01% 1651
2025
Q2
$36.2K Hold
453
﹤0.01% 1790
2025
Q1
$36.2K Sell
453
-10
-2% -$820 ﹤0.01% 1758
2024
Q4
$34.4K Buy
463
+152
+49% +$11.8K ﹤0.01% 1830
2024
Q3
$22.4K Buy
+311
New +$22K ﹤0.01% 2111
2024
Q2
Sell
-498
Closed -$35.7K 3261
2024
Q1
$35.7K Buy
+498
New +$33.3K ﹤0.01% 1809

Other funds holding PBH

CIBC Private Wealth Group's PBH Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Prestige Consumer Healthcare (PBH) stake by 56% in Q4 2025, selling an estimated $37.7K and leaving 484 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2008.

CIBC Private Wealth Group first reported a position in PBH in Q1 2024 and has held it in 7 quarters since. The position peaked at $68.6K in Q3 2025. 354 funds tracked by Wall St. Rank hold PBH as of Q4 2025.

  • CIBC Private Wealth Group held 484 shares of Prestige Consumer Healthcare worth $29.9K as of Q4 2025.
  • CIBC Private Wealth Group sold 616 Prestige Consumer Healthcare shares in Q4 2025, an estimated $37.7K.
  • Prestige Consumer Healthcare made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2008 holding.
  • CIBC Private Wealth Group first reported a position in Prestige Consumer Healthcare in Q1 2024 and has held it in 7 quarters since.
  • CIBC Private Wealth Group's Prestige Consumer Healthcare position peaked at $68.6K in Q3 2025.
  • 354 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.